<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001865125</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001672619</issuerCik>
      <issuerName>Enliven Therapeutics, Inc.</issuerName>
      <secFileNumber>001-39247</secFileNumber>
      <issuerAddress>
        <com:street1>205 PARK ROAD</com:street1>
        <com:city>BURLINGAME</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>94010</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>7206478519</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Derynck Mika K</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Director</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Jefferies LLC</name>
        <address>
          <com:street1>520 Madison Avenue, 4th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>158795</noOfUnitsSold>
      <aggregateMarketValue>9216461.80</aggregateMarketValue>
      <noOfUnitsOutstanding>71000000</noOfUnitsOutstanding>
      <approxSaleDate>08/04/2026</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>08/09/2022</acquiredDate>
      <natureOfAcquisitionTransaction>Stock Options</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Enliven Therapeutics</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>87373</amountOfSecuritiesAcquired>
      <paymentDate>08/09/2022</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>02/23/2023</acquiredDate>
      <natureOfAcquisitionTransaction>Stock Options</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Enliven Therapeutics</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>27567</amountOfSecuritiesAcquired>
      <paymentDate>02/23/2023</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>02/13/2024</acquiredDate>
      <natureOfAcquisitionTransaction>Stock Options</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Enliven Therapeutics</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>23364</amountOfSecuritiesAcquired>
      <paymentDate>02/13/2024</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>02/06/2025</acquiredDate>
      <natureOfAcquisitionTransaction>Stock Options</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Enliven Therapeutics</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>20491</amountOfSecuritiesAcquired>
      <paymentDate>02/06/2025</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <remarks>All sales are to be made pursuant to a previously signed/adopted 10b5-1 Selling Plan dated 04/08/2025, and all representations regarding material non-public information were made as of the adoption of the plan.</remarks>
    <noticeSignature>
      <noticeDate>08/04/2026</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>04/08/2025</planAdoptionDate>
      </planAdoptionDates>
      <signature>Mika Derynck</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
